Yagi et al. [7] conducted a randomized controlled trial on patients with essential hypertension to investigate whether plasma aldosterone level is associated with cognitive impairment and whether MR blockade alleviates cognitive dysfunction in hypertensive patients. Here, NR3C2 is linked to hypertensive disorder.